|
JPS54131665A
(en)
*
|
1978-04-04 |
1979-10-12 |
Chugai Shashin Yakuhin |
Production of porous resin
|
|
US8263650B2
(en)
|
1998-12-23 |
2012-09-11 |
Jazz Pharmaceuticals, Inc. |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
|
|
US8859619B2
(en)
|
1998-12-23 |
2014-10-14 |
Jazz Pharmaceuticals, Inc. |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
|
|
US7851506B2
(en)
|
1998-12-23 |
2010-12-14 |
Jazz Pharmaceuticals, Inc. |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
|
|
US9539330B2
(en)
|
1998-12-23 |
2017-01-10 |
Jazz Pharmaceuticals, Inc. |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
|
|
US8324275B2
(en)
|
1998-12-23 |
2012-12-04 |
Jazz Pharmaceuticals, Inc. |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
|
|
US8461203B2
(en)
|
1998-12-23 |
2013-06-11 |
Jazz Pharmaceuticals, Inc. |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
|
|
US8952062B2
(en)
|
1998-12-23 |
2015-02-10 |
Jazz Pharmaceuticals, Inc. |
Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
|
|
JP2005532362A
(en)
*
|
2002-06-13 |
2005-10-27 |
ノバルティス アクチエンゲゼルシャフト |
Calcium salt of indole-derived statin
|
|
JP2007195729A
(en)
*
|
2006-01-26 |
2007-08-09 |
Ntt Facilities Inc |
Furniture for storage
|
|
US8771735B2
(en)
|
2008-11-04 |
2014-07-08 |
Jazz Pharmaceuticals, Inc. |
Immediate release dosage forms of sodium oxybate
|
|
US8778398B2
(en)
|
2008-11-04 |
2014-07-15 |
Jazz Pharmaceuticals, Inc. |
Immediate release formulations and dosage forms of gamma-hydroxybutyrate
|
|
US9795567B2
(en)
|
2008-11-04 |
2017-10-24 |
Jazz Pharmaceuticals, Inc. |
Immediate release formulations and dosage forms of gamma-hydroxybutyrate
|
|
US11939285B2
(en)
|
2009-04-23 |
2024-03-26 |
Sun Pharmaceutical Industries, Inc. |
4-hydroxybutyric acid analogs
|
|
US11161798B2
(en)
|
2009-04-23 |
2021-11-02 |
Concert Pharmaceuticals, Inc. |
4-hydroxybutyric acid analogs
|
|
US10532971B2
(en)
|
2009-04-23 |
2020-01-14 |
Concert Pharmaceuticals, Inc. |
4-hydroxybutyric acid analogs
|
|
US10966931B2
(en)
|
2010-03-24 |
2021-04-06 |
Jazz Pharmaceuticals, Inc. |
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
|
|
US10813885B1
(en)
|
2010-03-24 |
2020-10-27 |
Jazz Pharmaceuticals, Inc. |
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
|
|
US11207270B2
(en)
|
2010-03-24 |
2021-12-28 |
Jazz Pharmaceuticals, Inc. |
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
|
|
US11090269B1
(en)
|
2010-03-24 |
2021-08-17 |
Jazz Pharmaceuticals, Inc. |
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
|
|
US10987310B2
(en)
|
2010-03-24 |
2021-04-27 |
Jazz Pharmaceuticals, Inc. |
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
|
|
US10959956B2
(en)
|
2010-03-24 |
2021-03-30 |
Jazz Pharmaceuticals, Inc. |
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
|
|
US10758488B2
(en)
|
2010-03-24 |
2020-09-01 |
Jazz Pharmaceuticals, Inc. |
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
|
|
JP2017165747A
(en)
*
|
2011-02-14 |
2017-09-21 |
コンサート ファーマシューティカルズ インコーポレイテッド |
4-hydroxybutyric acid deuterated analogs
|
|
JP2014513046A
(en)
*
|
2011-02-14 |
2014-05-29 |
コンサート ファーマシューティカルズ インコーポレイテッド |
Deuterated analog of 4-hydroxybutyric acid
|
|
US11554102B2
(en)
|
2012-12-14 |
2023-01-17 |
Jazz Pharmaceuticals Ireland Limited |
Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders
|
|
US10675258B2
(en)
|
2012-12-14 |
2020-06-09 |
Jazz Pharmaceuticals Ireland Limited |
Method of using gamma-hydroxybutyrate compositions for the treatment of disorders
|
|
US9555017B2
(en)
|
2012-12-14 |
2017-01-31 |
Jazz Pharmaceuticals Ireland Limited |
Methods of making a mixture of salts of gamma-hydroxybutyrate
|
|
US9132107B2
(en)
|
2012-12-14 |
2015-09-15 |
Jazz Pharmaceuticals Ireland Limited |
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
|
|
US8901173B2
(en)
|
2012-12-14 |
2014-12-02 |
Jazz Pharmacuticals, Inc. |
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
|
|
US10195168B2
(en)
|
2012-12-14 |
2019-02-05 |
Jazz Pharmaceuticlas Ireland Limited |
Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders
|
|
JP2016503762A
(en)
*
|
2012-12-14 |
2016-02-08 |
ジャズ ファーマシューティカルス アイルランド リミテッド |
Gamma-hydroxybutyrate composition and its use for the treatment of disease
|
|
US8591922B1
(en)
|
2012-12-14 |
2013-11-26 |
Jazz Pharmacuticals, Inc. |
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
|
|
US11077079B1
(en)
|
2015-02-18 |
2021-08-03 |
Jazz Pharmaceuticals Ireland Limited |
GHB formulation and method for its manufacture
|
|
US10398662B1
(en)
|
2015-02-18 |
2019-09-03 |
Jazz Pharma Ireland Limited |
GHB formulation and method for its manufacture
|
|
US11147782B1
(en)
|
2015-02-18 |
2021-10-19 |
Jazz Pharmaceuticals Ireland Limited |
GHB formulation and method for its manufacture
|
|
US11364215B1
(en)
|
2015-02-18 |
2022-06-21 |
Jazz Pharmaceuticals Ireland Limited |
GHB formulation and method for its manufacture
|
|
US12115144B2
(en)
|
2016-07-22 |
2024-10-15 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12115143B2
(en)
|
2016-07-22 |
2024-10-15 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12263150B2
(en)
|
2016-07-22 |
2025-04-01 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12263151B2
(en)
|
2016-07-22 |
2025-04-01 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11602512B1
(en)
|
2016-07-22 |
2023-03-14 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11602513B1
(en)
|
2016-07-22 |
2023-03-14 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11766418B2
(en)
|
2016-07-22 |
2023-09-26 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12257223B2
(en)
|
2016-07-22 |
2025-03-25 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11826335B2
(en)
|
2016-07-22 |
2023-11-28 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11839597B2
(en)
|
2016-07-22 |
2023-12-12 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11896572B2
(en)
|
2016-07-22 |
2024-02-13 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12239625B2
(en)
|
2016-07-22 |
2025-03-04 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11986451B1
(en)
|
2016-07-22 |
2024-05-21 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12097175B2
(en)
|
2016-07-22 |
2024-09-24 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12097176B2
(en)
|
2016-07-22 |
2024-09-24 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12109186B2
(en)
|
2016-07-22 |
2024-10-08 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12115142B2
(en)
|
2016-07-22 |
2024-10-15 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12226388B2
(en)
|
2016-07-22 |
2025-02-18 |
Flamel Ireland Limited |
Modified release gamma- hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12115145B2
(en)
|
2016-07-22 |
2024-10-15 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11504347B1
(en)
|
2016-07-22 |
2022-11-22 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12128021B1
(en)
|
2016-07-22 |
2024-10-29 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12138239B2
(en)
|
2016-07-22 |
2024-11-12 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12226389B2
(en)
|
2016-07-22 |
2025-02-18 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12144793B2
(en)
|
2016-07-22 |
2024-11-19 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12186296B1
(en)
|
2016-07-22 |
2025-01-07 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12186298B2
(en)
|
2016-07-22 |
2025-01-07 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11426373B2
(en)
|
2017-03-17 |
2022-08-30 |
Jazz Pharmaceuticals Ireland Limited |
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
|
|
US11400052B2
(en)
|
2018-11-19 |
2022-08-02 |
Jazz Pharmaceuticals Ireland Limited |
Alcohol-resistant drug formulations
|
|
US12167991B2
(en)
|
2019-03-01 |
2024-12-17 |
Flamel Ireland Limited |
Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
|
|
US12167992B2
(en)
|
2019-03-01 |
2024-12-17 |
Flamel Ireland Limited |
Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
|
|
US12226377B2
(en)
|
2019-03-01 |
2025-02-18 |
Flamel Ireland Limited |
Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
|
|
US11400065B2
(en)
|
2019-03-01 |
2022-08-02 |
Flamel Ireland Limited |
Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
|
|
US12303478B2
(en)
|
2019-03-01 |
2025-05-20 |
Flamel Ireland Limited |
Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
|
|
US12138233B2
(en)
|
2020-02-21 |
2024-11-12 |
Jazz Pharmaceuticals Ireland Limited |
Methods of treating idiopathic hypersomnia
|
|
US11779557B1
(en)
|
2022-02-07 |
2023-10-10 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US11583510B1
(en)
|
2022-02-07 |
2023-02-21 |
Flamel Ireland Limited |
Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
|
|
US12295926B1
(en)
|
2022-02-07 |
2025-05-13 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US12440449B2
(en)
|
2022-02-11 |
2025-10-14 |
Jazz Pharmaceuticals Ireland Limited |
Alcohol-resistant drug formulations
|